BioRunUp was created in 2010 by Mark Messier, below is his story

When I graduated high school I began working at Bank of America (BAC) while attending college.  Seeing the price of BAC fall to $3 a share, I had a sense that this was a good time to buy.  At the time I didn’t have much of a trading account, but I managed to buy about 1500 shares.  The recent upturn of the financial industry increased my portfolio and gave me the confidence and opportunity to branch out in other areas of the market.  That is when I discovered biotechs.

CTIC will always hold a special place in my heart, it was the first biotech that I ever traded.  I bought a few thousand shares in the $.30 range, and watched it grow to well over $1.  Next was HEB.  Although now former “HEBber’s” view that stock as a nightmare, I watch my original buy of $.96 climb to $4.54.  This ignited my interest in biotech stocks.  The more research I performed the more excited I got.  There seems to be a semi-predictable pattern with FDA Catalyst stocks.  

Simply put- Buy early, let the anticipation drive the price up, then sell. However, it is not that simple. In this confusing sector there was no reliable source of legitimate FDA catalysts.  From this void BioRunUp was created.

No matter what method you use to trade biotechs, one thing is clear- You need unbiased, accurate, and timely information.  BioRunUp.com was created to do just that.

I have always had a simplistic view of money. It is not what makes you happy. This viewpoint is very contrary to the majority on Wall Street to whom money is everything. These feelings only grew once we had our first child in 2007. We spent the first 7 years of our marriage traveling as much as possible. The tropical climate has always appealed to us, and we made a few trips down to Costa Rica, before purchasing a piece of land on the Pacific coast in 2007. I look forward to living and trading in a relaxed tropical climate and spending more time with my family.  This is something life in cubicle-ville can never offer.

Successful Trading

In 2009 my biotech portfolio increased by 273%, and another 216% in 2010.  

Let’s Ride the Waves of Biotech Together

Riding the ups and downs of biotechs can be a mix of skill and timing.  It does not look like this sector will be going anywhere any time soon.  As long as there is sickness, there will be a biotech market. With a healthy combination of run-ups, free shares, shorting, and options I feel there is a huge potential in these plays.  That being said, lets go ride the waves.

Mike Havrilla is a pharmacist, writer, marathon runner, and stock trader with experience that includes online investing since August 1997 and writing for investors since April 2007 with a focus on the healthcare sector. Mike holds Doctor of Pharmacy and Bachelor of Science (Biology) degrees from the University of Pittsburgh and worked in the pharmaceutical industry for Wyeth prior to pharmacy school. He is also an avid runner (50-75 miles per week) since 1992 and has completed 21 marathons with a personal best time of 2 hours, 54 minutes for the 26.2 mile race.

Send any questions or comments to comments@biorunup.com